Bernhard Gerstmayer
Overview
Explore the profile of Bernhard Gerstmayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
828
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francis N, Braun M, Neagle S, Peiffer S, Bohn A, Rosenthal A, et al.
Mol Ther Methods Clin Dev
. 2023 Oct;
31:101114.
PMID: 37790245
Engineered T cell therapies have shown significant clinical success. However, current manufacturing capabilities present a challenge in bringing these therapies to patients. Furthermore, the cost of development and manufacturing is...
2.
Boedecker-Lips S, Judel A, Holtz S, Mayer M, Klimpke P, Kraus D, et al.
J Clin Apher
. 2023 Jul;
38(5):590-601.
PMID: 37415533
Background: Gene therapies based on adeno-associated viruses (AAV) are a therapeutic option to successfully treat monogenetic diseases. However, the influence of pre-existing immunity to AAV can compromise the application of...
3.
Viklicky O, Hruba P, Tomiuk S, Schmitz S, Gerstmayer B, Sawitzki B, et al.
PLoS One
. 2017 Jan;
12(1):e0169624.
PMID: 28085915
Background: There is high medical need for safe long-term immunosuppression monotherapy in kidney transplantation. Selective targeting of post-transplant alloantigen-(re)activated effector-T cells by anti-TNF antibodies after global T cell depletion may...
4.
Aloia A, Petrova E, Tomiuk S, Bissels U, Deas O, Saini M, et al.
Breast Cancer Res
. 2015 Nov;
17(1):146.
PMID: 26607327
Introduction: Chemotherapy resistance resulting in incomplete pathologic response is associated with high risk of metastasis and early relapse in breast cancer. The aim of this study was to identify and...
5.
Letzkus M, Luesink E, Starck-Schwertz S, Bigaud M, Mirza F, Hartmann N, et al.
Clin Transl Med
. 2015 May;
3:36.
PMID: 25984272
Background: Clinically useful biomarkers for patient stratification and monitoring of disease progression and drug response are in big demand in drug development and for addressing potential safety concerns. Many diseases...
6.
Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, et al.
Nat Methods
. 2014 Jun;
11(8):809-15.
PMID: 24973947
MicroRNAs are important negative regulators of protein-coding gene expression and have been studied intensively over the past years. Several measurement platforms have been developed to determine relative miRNA abundance in...
7.
Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens D, Miqueu P, et al.
J Clin Invest
. 2010 May;
120(6):1848-61.
PMID: 20501943
Identifying transplant recipients in whom immunological tolerance is established or is developing would allow an individually tailored approach to their posttransplantation management. In this study, we aimed to develop reliable...
8.
Ong L, Li W, Oldigs J, Kaminski A, Gerstmayer B, Piechaczek C, et al.
Tissue Eng Part C Methods
. 2010 Jan;
16(5):1069-81.
PMID: 20073989
CD133+ cells are hemangioblasts that have capacity to generate into both hematopoietic and endothelial cells (ECs). Hypoxia/normoxia has shown to be the regulator of the balance between stemness and differentiation....
9.
Paulsen S, Larsen L, Jelsing J, Janssen U, Gerstmayer B, Vrang N
J Neurosci Methods
. 2008 Oct;
177(1):87-93.
PMID: 18955080
In order to identify novel genes involved in appetite and body weight regulation we have developed a microarray based method suitable for detecting small changes in gene expression in discrete...
10.
Mashreghi M, Klemz R, Knosalla I, Gerstmayer B, Janssen U, Buelow R, et al.
J Immunol
. 2008 Jun;
180(12):7919-30.
PMID: 18523255
The induction of heme oxygenase 1 (HO-1) by a single treatment with cobalt protoporphyrin (CoPPIX) protects against inflammatory liver failure and ischemia reperfusion injury after allotransplantation. In this context, the...